Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
出版年份 2019 全文链接
标题
Cost-effectiveness of gastro-resistant risedronate tablets for the treatment of postmenopausal women with osteoporosis in France
作者
关键词
Cost-effectiveness, Economic evaluation, Osteoporosis, Risedronate, Treatment
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 30, Issue 3, Pages 649-658
出版商
Springer Nature
发表日期
2019-01-30
DOI
10.1007/s00198-018-04821-7
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Quality of life for up to 18 months after low-energy hip, vertebral, and distal forearm fractures—results from the ICUROS
- (2017) A. Svedbom et al. OSTEOPOROSIS INTERNATIONAL
- The projected public health and economic impact of vitamin D fortified dairy products for fracture prevention in France
- (2017) Mickael Hiligsmann et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX® in Portugal
- (2016) Andréa Marques et al. CALCIFIED TISSUE INTERNATIONAL
- A systematic review and economic evaluation of bisphosphonates for the prevention of fragility fractures
- (2016) Sarah Davis et al. HEALTH TECHNOLOGY ASSESSMENT
- Public health impact and economic evaluation of vitamin D-fortified dairy products for fracture prevention in France
- (2016) M. Hiligsmann et al. OSTEOPOROSIS INTERNATIONAL
- Changes in number and incidence of hip fractures over 12 years in France
- (2015) Karine Briot et al. BONE
- Residual effect after oral bisphosphonate treatment and healthy adherer effects—the Swedish adherence register analysis (SARA)
- (2014) O. Ström et al. OSTEOPOROSIS INTERNATIONAL
- A Systematic Review of Cost-Effectiveness Analyses of Drugs for Postmenopausal Osteoporosis
- (2014) Mickaël Hiligsmann et al. PHARMACOECONOMICS
- Health-Related Quality of Life and Utility Scores in People with Mental Disorders: A Comparison with the Non-Mentally Ill General Population
- (2014) Amélie Prigent et al. International Journal of Environmental Research and Public Health
- Health Technology Assessment in Osteoporosis
- (2013) Mickael Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- Consolidated Health Economic Evaluation Reporting Standards (CHEERS) Statement
- (2013) Don Husereau et al. VALUE IN HEALTH
- Osteoporosis in the European Union: a compendium of country-specific reports
- (2013) A. Svedbom et al. Archives of Osteoporosis
- Cost-effective intervention thresholds against osteoporotic fractures based on FRAX® in Switzerland
- (2012) K. Lippuner et al. OSTEOPOROSIS INTERNATIONAL
- Treatment of postmenopausal osteoporosis with delayed-release risedronate 35 mg weekly for 2 years
- (2012) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- The Clinical and Economic Burden of Poor Adherence and Persistence with Osteoporosis Medications in Ireland
- (2012) Mickaël Hiligsmann et al. VALUE IN HEALTH
- The importance of integrating medication adherence into pharmacoeconomic analyses: the example of osteoporosis
- (2012) Mickaël Hiligsmann et al. Expert Review of Pharmacoeconomics & Outcomes Research
- Cost of non-persistence with oral bisphosphonates in post-menopausal osteoporosis treatment in France
- (2011) François-Emery Cotté et al. BMC HEALTH SERVICES RESEARCH
- Predictors of institution admission in the year following acute hospitalisation of elderly people
- (2011) Moustapha Dramé et al. Journal of Nutrition Health & Aging
- Efficacy and safety of a novel delayed-release risedronate 35 mg once-a-week tablet
- (2011) M. R. McClung et al. OSTEOPOROSIS INTERNATIONAL
- A reappraisal of generic bisphosphonates in osteoporosis
- (2011) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Cost Effectiveness of Denosumab Compared with Oral Bisphosphonates in the Treatment of Post-Menopausal Osteoporotic Women in Belgium
- (2011) Mickaël Hiligsmann et al. PHARMACOECONOMICS
- Potential Clinical and Economic Impact of Nonadherence with Osteoporosis Medications
- (2010) Mickaël Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- The clinical and economic burden of non-adherence with oral bisphosphonates in osteoporotic patients
- (2010) Mickaël Hiligsmann et al. HEALTH POLICY
- The cost-effectiveness of risedronate in the UK for the management of osteoporosis using the FRAX®
- (2009) F. Borgström et al. OSTEOPOROSIS INTERNATIONAL
- Development and Validation of a Markov Microsimulation Model for the Economic Evaluation of Treatments in Osteoporosis
- (2009) Mickaël Hiligsmann et al. VALUE IN HEALTH
- Utility Values Associated with Osteoporotic Fracture: A Systematic Review of the Literature
- (2008) Mickaël Hiligsmann et al. CALCIFIED TISSUE INTERNATIONAL
- Fracture Outcomes Related to Persistence and Compliance With Oral Bisphosphonates
- (2008) Arlene M Gallagher et al. JOURNAL OF BONE AND MINERAL RESEARCH
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2008) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started